Zimmer Biomet Holdings (ZBH)
NYSE:ZBH
Want to see ZBH full AI Analyst Report?
Earnings Data
Report Date
Aug 04, 2026Before Open (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
2.02Last Year’s EPS
2.07Same Quarter Last Year
Based on 18 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented more positive developments than negative ones: solid top‑line growth (reported and organic), an EPS beat and raised EPS and free cash flow guidance, strong cash generation, accelerating performance from strategic acquisitions (Paragon 28) and clear momentum in technology and robotics (Monogram enrollment complete, ROSA/TMINI adoption). Offsetting items include short‑term disruption from the U.S. salesforce transformation and legacy knee transitions, some international go‑to‑market disruption, a one‑time tariff benefit that partially pulled forward upside, and higher interest expense tied to acquisition debt. On balance the company appears to be executing on its strategic priorities while managing expected transitional headwinds.Company Guidance
Revenue and Organic Growth
Net sales of $2.087 billion, up 9.3% on a reported basis and up 2.9% on an organic constant currency basis (ex-Paragon 28). U.S. sales grew 3.2% and International sales grew 2.5% in Q1 2026.
Adjusted EPS and GAAP EPS Outperformance
Adjusted EPS of $2.09, up ~15% year-over-year (from $1.81 prior year adjusted); GAAP diluted EPS of $1.22 vs. $0.91 in prior year quarter.
Margin and Profitability Metrics
Adjusted gross margin of 73% (higher than Q1 2025) and adjusted operating margin of 27.3%. Company raised full-year adjusted EPS guidance to $8.40–$8.55 (from $8.30–$8.45).
Free Cash Flow and Cash Generation
Operating cash flow of $359 million and free cash flow of $246 million in Q1. Ended quarter with approximately $424 million in cash and cash equivalents. Free cash flow growth guidance raised to 9%–11% (from 8%–10%).
Technology and Digital Offerings Driving Growth
Technology, data, bone cement and surgical business grew nearly 12% in the quarter; ROBOT/technology sales strong (TMINI referenced growing ~30% in remarks) with ROSA and TMINI momentum and robust adoption of OrthoGrid (strongest quarter to date).
Monogram and Robotic Roadmap
Completed enrollment in 102‑patient Monogram clinical study; expecting U.S. semiautonomous Monogram launch in early 2027 and fully autonomous version in late 2027/early 2028; targeting to hire >200 robotic clinical sales reps by end of 2027.
Paragon 28 and M&A Integration
Paragon 28 contributed ~100 basis points to reported sales growth in 2026, with first quarter growth accelerating ~200 basis points sequentially from Q4 2025 and trending back toward double-digit growth.
Share Repurchase and Capital Allocation
Repurchased $250 million of shares in Q1; fully diluted shares outstanding 195.8 million. Company continues to assume up to $750 million of share repurchases for the year.
Operational Improvements and Strategic Hires
Progress on SKU rationalization, lowering days of inventory and expanding manufacturing into lower‑cost geographies; appointed Dr. Jonathan (Chief Science, Technology & Medical Affairs) to lead AI/robotics/software strategy.
ZBH Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ZBH Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 28, 2026 | $92.59 | $82.80 | -10.57% |
Feb 10, 2026 | $89.49 | $91.15 | +1.86% |
Nov 05, 2025 | $102.63 | $87.08 | -15.15% |
Aug 07, 2025 | $90.44 | $97.66 | +7.99% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Zimmer Biomet Holdings (ZBH) report earnings?
Zimmer Biomet Holdings (ZBH) is schdueled to report earning on Aug 04, 2026, Before Open (Confirmed).
What is Zimmer Biomet Holdings (ZBH) earnings time?
Zimmer Biomet Holdings (ZBH) earnings time is at Aug 04, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ZBH EPS forecast?
ZBH EPS forecast for the fiscal quarter 2026 (Q2) is 2.02.